World Health Organization

Slides:



Advertisements
Similar presentations
1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
Advertisements

1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
1 |1 | Countries using and planning to introduce IPV.
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
World Health Organization
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 |1 | Countries using and planning to introduce IPV.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
A program of the THE GLOBAL VACCINE ACTION PLAN SHAPING IMMUNIZATION PROGRAMMES IN THE CURRENT DECADE Thomas Cherian Department of Immunization, Vaccines.
Global Overview Progress Towards Global Immunization Goals 21 st inter-country meeting of national managers of the Expanded Programme on Immunization Cairo,
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.
AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.
The changing vaccination landscape and the sources of vaccination data
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Vaccine in National Immunization Programme Update April 2016.
Data quality for polio eradication: Accuracy & reliability
SAGE 2010 Sampling Distribution
2016 Immunization Coverage Data at Subnational Level
financial requirements
reporting rate of discarded cases* per 100'000 population**
Progress and Challenges with achieving Universal Immunization Coverage
World Health Organization
Session 1: New Opportunities and New Direction
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
World Health Organization
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries having introduced HepB vaccine
No new positives this week
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
World Health Organization
Presentation transcript:

World Health Organization 21 November 2017 Progress Towards Global Immunization Goals - 2016 Summary presentation of key indicators Updated July 2017

World Health Organization Global and Regional Immunization coverage with DTP3, 1980-2016, global coverage at 86% in 2016 21 November 2017 Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2017.

Immunization coverage with DTP3 vaccines in infants (from <50%), 2016 <50% (8 countries or 4%) 50-79% (27 countries or 14%) 80-89% (29 countries or 15%) >=90% (130 countries or 67%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 19 July 2017 Not applicable

World Health Organization Coverage with three doses of diphtheria, tetanus, and pertussis (DTP3) containing vaccines, by country income levels, 1980-2016 21 November 2017 96% High-income countries 86% 78% Global Low-income countries Source: WHO/UNICEF coverage estimates 2016 revision, July 2017, and Country Income Categories (World Bank), as of July 2017 (2016 GNI per capita). Income classification not available for: Cook Islands and Niue. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 17 July 2017.

Number of countries reached and sustained 90% coverage with 3 doses of DTP containing vaccines since 2000 and global DTP3 coverage Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2017.

World Health Organization 19.5 million infants not immunized (DTP3), 2016 21 November 2017 Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. United Nations, Population Division. The World Population Prospects - 2017 revision. New York, 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 17 July 2017.

GLOBAL Annual surviving infants cohort = 136.1 million World Health Organization GLOBAL Annual surviving infants cohort = 136.1 million 21 November 2017 86% DTP3 coverage 116.5 million children vaccinated Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. United Nations, Population Division. The World Population Prospects - 2017 revision. New York, 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 28 July 2017.

Top 10 countries with most under- and un-vaccinated children (DTP3), in 2016 Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2017.

“Developing”* countries with all districts achieving at least 80% DTP3 coverage, 2016 All districts >= 80% (42 countries or 27%) *155 developing countries and economies in transition per UN World Economic & Social Survey, 2017 classification Not all districts >=80% (91 countries or 59%) No district data available (22 countries or 14%) Developed economies (39 countries ) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 Member States. Date of slide: 26 July 2017 Not applicable

“Developing”* countries with % of districts achieving at least 80% DTP3 coverage, 2016 <50% of districts (23 countries or 15%) *155 developing countries and economies in transition per UN World Economic & Social Survey, 2017 classification 50-79% of districts (30 countries or 19%) 80-99% of districts (38 countries or 25%) 100% of districts (42 countries or 27%) Developed economies (39 countries ) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 Member States. Date of slide: 26 July 2017 Not Available (22 countries or 14%) Not applicable

World Health Organization Number of vaccines/antigens introduced in national immunization schedules - 2000 compared to July 2016 21 November 2017 Selected antigens are : Diphtheria, Tetanus, Pertussis, Measles, Polio - universal use Hepatitis B, Heamophilius Influenza type B, Pneumococcal conjugate Rotavirus Rubella 2000 5 antigens (DTP, Measles and Polio) 6 antigens 7 antigens 8 antigens 9 antigens ≥10 antigens The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Not applicable 2016 Not available Source:WHO/IVB Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization 194 WHO Member States. Date of slide: 31 July 2017.

Polio Eradication Progress, 1988 – 2016 World Health Organization Polio Eradication Progress, 1988 – 2016 21 November 2017 Certified polio-free regions (126 countries) Endemic with wild poliovirus ( 3 countries) Not certified but non-endemic (65 countries) Source: WHO/POLIO database, as of Aug 2017. 194 member states. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved

World Health Organization Progress in Polio Eradication, Estimated and Reported Polio Cases, 1985-2016 21 November 2017 1988: WHA Resolution to Eradicate Polio 2000: Original Target Date for Interruption of Transmission Reported cases: 2 971 Estimated cases: 3 500 1999: WHA Resolution to accelerate polio eradication activities 2016: Reported wild poliovirus cases: 37 Source: WHO/POLIO database, as of Aug 2017. 194 member states.

Immunization coverage with 1st dose of measles containing vaccines in infants, 2016 <50% (7 countries or 4%) 50-79% (32 countries or 16%) 80-89% (32 countries or 16%) >=90% (123 countries or 64%) Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 19 July 2017 Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Not applicable

World Health Organization ARE WE ON TRACK TO REACH OUR GVAP COVERAGE GOALS ? Global Immunization 1980-2016 and projections to reach 90% global coverage goals in 2020 - MCV1 coverage 21 November 2017 Source: WHO/UNICEF coverage estimates 2016 revision, July 2017 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2017

41 Countries. have eliminated MNT between 2000 & 2016 41 Countries* have eliminated MNT between 2000 & 2016 *Plus Ethiopia except Somali region, 16/17 regions in Philippines, and Punjab region of Pakistan - leaving 18 countries yet to eliminate MNT MNT eliminated from 2000-2016 Source: WHO/UNICEF Database. Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization. Date of slide: 06 July 2017. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2017. All rights reserved MNT not eliminated MNT eliminated before 2000

Countries providing vitamin A supplementation with routine and/or supplementary immunization activities, 2016 Vitamin A distributed with routine and supplementary immunization activities (21 countries or 29%) Vitamin A distributed only with routine immunization services (29 countries or 40%) Vitamin A distributed only with supplementary immunization activities (6 countries or 8%) Source: WHO/UNICEF database as at 11 July 2017. Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 28 July 2017. Not available/No Vitamin A distribution (17 countries or 23%) Not a Countdown country (119) or Countdown country for which Vitamin A deficiency is not a public health problem (2) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved

World Health Organization Number of countries having introduced Hepatitis B vaccine and global infant coverage for Hepatitis B 3rd dose (HepB3), 1989-2016 21 November 2017 Source: WHO/UNICEF coverage estimates 2016 revision, July 2017 , and WHO database as at 06 July 2016. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 26 July 2017. 2016: excluding 3 countries where HepB administered for adolescents

Immunization coverage with HepB3 in infants, 2016 <50% (7 countries or 4%) 50-79% (32 countries or 16%) 80-89% (28 countries or 14%) >=90% (118 countries or 61%) Not available / HepB not introduced or no coverage data available (9 countries or 5%) Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 24 July 2017. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved

World Health Organization Countries having introduced Hib vaccine in the last 20 years (1997-2016) 21 November 2017 1997 29 countries introduced 2 countries partially introduced 2016 190 countries introduced 1 countries partially introduced Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. 194 WHO Member States. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. Date of slide: 27 July 2017. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2017. All rights reserved

Immunization coverage with PCV3 in infants, 2016 <50% (11 countries or 6%) 50-79% (25 countries or 13%) 80-89% (25 countries or 13%) >=90% (68 countries or 35%) PCV in schedule but no coverage data available (6 countries or 3%) Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 27 July 2017 Not available / not in national immunization schedule (59 countries or 30%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2017. All rights reserved

Immunization coverage with Rotavirus vaccine in infants, 2016 <50% (9 countries or 5%) 50-79% (22 countries or 11%) 80-89% (15 countries or 8%) >=90% (38 countries or 20%) Rotavirus vaccine in schedule but no coverage data available (7 countries or 4%) Source: WHO/UNICEF coverage estimates 2016 revision, July 2017. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 24 July 2017 Not available / not in national immunization schedule (103 countries or 53%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2017. All rights reserved

World Health Organization Countries with a 3-5 year strategic plan for the national immunization system, 2016 21 November 2017 Yes (146 countries or 75%) No (32 countries or 16%) No data (16 countries or 8%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO/IVB Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization. 194 WHO Member States Date of slide: 28 July 2017. Not applicable

World Health Organization Countries with a national annual work plan for immunization services, 2016 21 November 2017 Yes (163 countries or 84%) No (12 countries or 6%) No data (19 countries or 10%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO/IVB Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization. 194 WHO Member States. Date of slide: 28 July 2017. Not applicable

World Health Organization Countries having a policy being implemented for immunization injection safety, 2016 21 November 2017 Yes (148 countries or 76%) No (17 countries or 9%) No data (29 countries or 15%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Source: WHO/IVB Database, as at 11 July 2017. Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization. 194 WHO Member States. Date of slide: 28 July 2017. Not applicable

National Immunization Technical Advisory Groups (NITAGs) in 2016 83 Countries meeting the 6 NITAG criteria 122 Countries having a NITAG with administrative or legislative basis 122 Countries Reporting the Existence of A NITAG with Terms of Reference 129 Countries Reporting the Existence of a NITAG Data source: WHO/IVB Database, as at 21 July 2017. Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization. 194 WHO Member States. Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Not applicable